CME Group Inc.
CME Financial Financial Data & Stock Exchanges
CME Group Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.5 billion, up 6.37% from fiscal 2024.
- Revenue
- +13.0%
- EPS
- +16.5%
- Free cash flow
- +12.7%
- Total debt
- +0.11%
Quarter to September 2026, against a year earlier
Follow CME
Alert me
CME Group Inc. (CME) P/S ratio
As of 6 November 2026, CME Group Inc. (CME) trades at a P/S ratio of 15.7×. Over the past ten years it has ranged from 8.3× (January 2016) to 19.2× (March 2022); the current reading is higher than 85% of that period. That is above the Financial Data & Stock Exchanges industry median of 6.8× and above the Financial sector median of 2.3×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 15.1× | 10.63% |
| FY2024 | 13.6× | 1.12% |
| FY2023 | 13.5× | 11.52% |
| FY2022 | 12.1× | (30.83%) |
| FY2021 | 17.5× | 30.89% |
| FY2020 | 13.3× | (9.44%) |
| FY2019 | 14.7× | (1.46%) |
| FY2018 | 14.9× | 11.07% |
| FY2017 | 13.5× | 25.29% |
| FY2016 | 10.7× | 17.28% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 13.5× | 14.38% |
| Jun 2026 | 11.8× | (25.10%) |
| Mar 2026 | 15.7× | 4.25% |
| Dec 2025 | 15.1× | (0.85%) |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| TRU TransUnion compare | 3.1× |
| COIN Coinbase Global, Inc. compare | 6.5× |
| NDAQ Nasdaq, Inc. compare | 6.5× |
| CBOE Cboe Global Markets, Inc. compare | 7.0× |
| SPGI S&P Global Inc. compare | 8.4× |
| ICE Intercontinental Exchange Inc. compare | 9.0× |
| MCO Moody's Corporation compare | 10.9× |
| MSCI MSCI Inc compare | 13.8× |
| CME CME Group Inc. | 15.8× |
| Financial Data & Stock Exchanges industry median | 6.8× |
| Financial sector median | 2.3× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on CME
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- The full statement